# SELEXIPAG
> **ANDA214367** · Abbreviated New Drug Application (Generic) · Sponsor: MSN LABORATORIES PRIVATE LTD · Approved 2026-01-16
## Drug
- **FDA Application Number:** ANDA214367
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SELEXIPAG
- **Generic name:** Selexipag
- **Active ingredients:** SELEXIPAG
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** MSN LABORATORIES PRIVATE LTD
- **First approval:** 2026-01-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214367)
---
*AI Analytics · CC0 1.0*